Blood-Based Measurable Residual Disease by Clonotypic Mass Spectrometry is Prognostic in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
Titel:
Blood-Based Measurable Residual Disease by Clonotypic Mass Spectrometry is Prognostic in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
Auteur:
Slade, Michael J. Fortier, Julie Khaled, Abir Fiala, Mark McDonald, Zac Zaydman, Mark A. Wan, Fei Schroeder, Mark A. Stockerl-Goldstein, Keith Yang, Liqiang Vij, Ravi